CoChat

The DOI matches its Crossref record; 67 of the 69 references it cites were found in a registry or an index; 4 of the 67 sources its claims cite were checked for support.

Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review

Open access
de Zwart, P. L., Jeronimus, B. F., de Jonge, P. · 2019 · Epidemiology and Psychiatric Sciences

Abstract

Aims.: For the past quarter of a century, Frank et al.’s (1991) consensus-based definitions of major depressive disorder (MDD) episode, remission, recovery, relapse and recurrence have been the paramount driving forces for consistency in MDD research as well as in clinical practice. This study aims to review the evidence for the empirical validation of Frank et al.’s proposed concept definitions and to discuss evidence-based modifications. Methods.: A literature search of Web of Science and PubMed from 1/1/1991 to 08/30/2017 identified all publications which referenced Frank et al.’s request for definition validation. Publications with data relevant for validation were included and checked for referencing other studies providing such data. Results.: A total of 56 studies involving 39 315 subjects were included, mainly presenting data to validate the severity and duration thresholds for defining remission and recovery. Most studies indicated that the severity threshold for defining remission should decrease. Additionally, specific duration thresholds to separate remission from recovery did not add any predictive value to the notion that increased remission duration alleviates the risk of reoccurrence of depressive symptoms. Only limited data were available to validate the severity and duration criteria for defining a depressive episode. Conclusions.: Remission can best be defined as a less symptomatic state than previously assumed (Hamilton Rating Scale for Depression, 17-item version (HAMD-17) ⩽4 instead of ⩽7), without applying a duration criterion. Duration thresholds to separate remission from recovery are not meaningful. The minimal duration of depressive symptoms to define a depressive episode should be longer than 2 weeks, although further studies are required to recommend an exact duration threshold. These results are relevant for researchers and clinicians aiming to use evidence-based depression outcomes.

Overview

CoChat Summary

TL;DR

This systematic review of 56 studies covering 39,315 subjects found that Frank et al.’s consensus definitions are only partly empirically supported. The authors conclude remission is best defined as HAMD-17 ≤4 rather than ≤7 without a duration criterion, duration thresholds separating remission from recovery are not meaningful, and the minimal depressive episode duration should be longer than 2 weeks though an exact threshold remains unclear.

Key findings

  • Across 56 included studies and 39,315 subjects, most evidence concerned severity and duration thresholds for remission and recovery; only limited data were available to validate severity and duration criteria for defining a depressive episode.
  • Remission can best be defined as HAMD-17 ≤4 instead of ≤7, roughly equivalent to MADRS ≤5, and without applying a duration criterion; specific duration thresholds to separate remission from recovery did not add predictive value, and the majority of studies did not show a clear point of rarity.
  • The minimal duration of depressive symptoms to define a depressive episode should be longer than 2 weeks, although the review refrains from recommending an exact threshold; two general-population studies found 25% of episodes remitted after 4 weeks and 50% after 8–12 weeks.
  • Only one study provided data on the fully symptomatic threshold, advising HAMD-17 ≥7 or ≥14 depending on the CGI-S gold standard, so there was not enough evidence to make recommendations for that threshold.

Methods

  • Systematic review largely adhering to PRISMA; searched Web of Science and PubMed from 1 January 1991 to 30 August 2017 for publications referencing Frank et al.’s request for definition validation, without language restrictions.
  • Excluded studies not focused on MDD, non-empirical studies, irrelevant study types, and those evaluating associations or cause-effect relations; focused on HAMD-17 and MADRS cut-offs and on survival curves or equivalent data for duration thresholds.
  • Two authors extracted data independently and resolved discrepancies by discussion; reference checks added studies. From 1,570 identified papers, 214 duplicates and 26 non-obtainable papers were removed, 117 papers remained after selection, 49 additional records came from references, 110 were excluded after full-text assessment, yielding 56 included studies.

Limitations

  • Stated by the authors: included studies had greatly varying populations and treatments; a substantial part of the data had to be extracted from survival curves that only rarely showed confidence intervals and often lacked a clearly labelled time axis, making it difficult to assess exactly when measurement began.
  • Stated by the authors: comparing studies was not straightforward because they differed in populations, operationalisations of remission, recovery, relapse and recurrence, and often uncontrolled treatments.
  • Evident from the text: evidence was especially limited for validating the fully symptomatic threshold and the duration threshold for a depressive episode, with the authors noting that a prospective general-population study screening frequently for depressive symptoms is still required.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1017/s2045796018000227

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Time course of depressive symptomatology in a hypothetical patient, showing an MDD episode, remission, relapse, recovery and recurrence. These stages are operationalised using two severity criteria (S1, S2), and three duration criteria (D, E, F). S1: Severity threshold separating asymptomatic from partially symptomatic range; S2: Severity threshold separating partially symptomatic range from fully symptomatic range; t1, Start of MDD episode; t2, Start of episode remission; t3, End of episode remission; t4, Relapse of MDD episode; t5: Start of episode recovery and end of MDD episode; t6, Start of MDD recurrence.
Fig. 1. Time course of depressive symptomatology in a hypothetical patient, showing an MDD episode, remission, relapse, recovery and recurrence. These stages are operationalised using two severity criteria (S1, S2), and three duration criteria (D, E, F). S1: Severity threshold separating asymptomatic from partially symptomatic range; S2: Severity threshold separating partially symptomatic range from fully symptomatic range; t1, Start of MDD episode; t2, Start of episode remission; t3, End of episode remission; t4, Relapse of MDD episode; t5: Start of episode recovery and end of MDD episode; t6, Start of MDD recurrence.CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 0 Not valid · 35 Not checked · 39 Own results and interpretations

42 more claims

Create a free account to see all 78 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 13
  • Probably not a substantial claim. 24

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 67 references

Research works printed but not linked: 2

  1. 1993, The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research
  2. 2013, Diagnostic and Statistical Manual of Mental Disorders (DSM-5®)

Cited by

See all 189

Metadata

Authors
de Zwart, P. L., Jeronimus, B. F., & de Jonge, P.
Affiliations
University Medical Center Groningen (NL)
Venue
Epidemiology and Psychiatric Sciences
Published
2018-05-17
Volume
28
Issue
5
Pages
544-562
ISSN
  • 2045-7960 (ISSN-L)
  • 2045-7979
OpenAlex
W2803564469
Cited by
189
References
69
Citations by year
2026: 15 · 2025: 26 · 2024: 38 · 2023: 25 · 2022: 26 · 2021: 24 · 2020: 19 · 2019: 11 · 2018: 3
FWCI
1.69
Type
journal article
Language
en
Open access
Locations
  • Epidemiology and Psychiatric Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
Keywords
major depressive disorder, remission, recovery, relapse, recurrence, severity thresholds, duration thresholds, remission duration, depressive symptoms, outcome measures
MeSH terms
Adult, Antidepressive Agents, Depression, Depressive Disorder, Humans, Psychiatric Status Rating Scales, Recurrence, Remission Induction, Outcome Assessment, Health Care, Evidence-Based Practice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review. https://app.cochat.ai/papers/10.1017/s2045796018000227
The paper
de Zwart, P. L., Jeronimus, B. F., & de Jonge, P. (2019). Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796018000227

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.